2006
DOI: 10.1002/jmv.20748
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology of Epstein–Barr virus, cytomegalovirus, and kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay

Abstract: A multiplex polymerase chain reaction (PCR) has been developed for the simultaneous detection of Epstein-Barr virus (EBV), cytomegalovirus (CMV), and Kaposi's sarcoma-associated herpesvirus (KSHV) in a clinical sample. Primers of multiplex PCR were designed to amplify specific regions of the EBV EBNA1, CMV IE2, and KSHV LANA genes. This multiplex PCR assay was found to have detection sensitivities of 1-10 copies of purified viral DNA cloned into the plasmid. To assess diagnostic and pre-clinical applications w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
18
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(22 citation statements)
references
References 32 publications
3
18
1
Order By: Relevance
“…Thus, in agreement with their ability to establish latency in B lymphocytes and in monocyte progenitor cells, respectively, EBV and HCMV are probably carried by circulating blood cells when transmitted from the donor to the recipient. Remarkably, the prevalence of EBV and HCMV DNA in preservation and washing solutions was similar to the prevalence of EBV DNA and HCMV DNA in the peripheral blood of healthy blood donors reported in the literature (ie, ∼8%-40% and 1%-3%, respectively [16,17]). …”
Section: Discussionsupporting
confidence: 77%
“…Thus, in agreement with their ability to establish latency in B lymphocytes and in monocyte progenitor cells, respectively, EBV and HCMV are probably carried by circulating blood cells when transmitted from the donor to the recipient. Remarkably, the prevalence of EBV and HCMV DNA in preservation and washing solutions was similar to the prevalence of EBV DNA and HCMV DNA in the peripheral blood of healthy blood donors reported in the literature (ie, ∼8%-40% and 1%-3%, respectively [16,17]). …”
Section: Discussionsupporting
confidence: 77%
“…19 The presence of active viral shedding was determined by growing EBV Ϫ Karpas-422 cells in MWCL-1-conditioned media followed by PCR amplification of EBNA1 in the treated Karpas-422 cells.…”
Section: Assessment Of Ebv Infectionmentioning
confidence: 99%
“…The PCR primers for amplification of IE-1/IE-2 genes were used as previously reported. 10 The b-actin gene was used as an internal control. Comparative expression levels of the IE-1/ IE-2 mRNAs were calculated according to expression levels of the b-actin mRNA.…”
Section: Detection Of Viral Mrnamentioning
confidence: 99%